Survival analysis of Stage IIA1 and IIA2 cervical cancer patients

Taiwanese Journal of Obstetrics and Gynecology

Volumn 52, Issue 1, 2013, Pages 33-38

  Lai, Jerry Cheng Yen ^a   Chou, Yiing Jenq ^a   Huang, Nicole ^a   Tsai, Jai Jen ^a   Huang, Sheng Miauh ^b   Yang, Yuh Cheng ^c,d,e   Chang, Chih Long ^c   Wang, Kung Liahng ^c,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bulky tumor; Stage IIA; Staging criteria; Survival; Tumor size

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84878020092     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2013.01.006     Document Type: Article

References (31)

1. Sevin B.U., Lu Y., Bloch D.A., Nadji M., Koechli O.R., Averette H.E. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996, 78:1438-1446.
2. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K., et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992, 69:181-186.
3. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990, 38:352-357.
4. Gauthier P., Gore I., Shingleton H.M., Soong S.J., Orr J.W., Hatch K.D. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 1985, 66:569-574.
5. Singh N., Arif S. Histopathologic parameters of prognosis in cervical cancer-a review. Int J Gynecol Cancer 2004, 14:741-750.
6. Pecorelli S., Zigliani L., Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009, 105:107-108.
7. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997, 350:535-540.
8. Huang H.J., Chang T.C., Hong J.H., Tseng C.J., Chou H.H., Huang K.G., et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 2003, 13:204-211.
9. Kristensen G.B., Abeler V.M., Risberg B., Trop C., Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 1999, 74:245-251.
10. Trattner M., Graf A.H., Lax S., Forstner R., Dandachi N., Haas J., et al. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001, 82:11-16.
11. Turan T., Yildirim B.A., Tulunay G., Boran N., Kose M.F. Prognostic effect of different cut-off values (20mm, 30mm and 40mm) for clinical tumor size in FIGO stage IB cervical cancer. Surg Oncol 2010, 19:106-113.
12. Finan M.A., DeCesare S., Fiorica J.V., Chambers R., Hoffman M.S., Kline R.C., et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?. Gynecol Oncol 1996, 62:139-147.
13. Rutledge T.L., Kamelle S.A., Tillmanns T.D., Gould N.S., Wright J.D., Cohn D.E., et al. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?. Gynecol Oncol 2004, 95:70-76.
14. Perez C.A., Grigsby P.W., Chao K.S., Mutch D.G., Lockett M.A. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998, 41:307-317.
15. Eifel P.J., Jhingran A., Levenback C.F., Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 2009, 19:2-7.
16. Garg G., Shah J.P., Toy E.P., Christensen C., Deppe G., Asaad R., et al. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?. Int J Gynecol Cancer 2011, 21:711-716.
17. Taiwan Cancer Registry Annual Report 2011. Taiwan Cancer Registry website. Published 2011 [accessed 05.11.11]. http://crs.cph.ntu.edu.tw.
18. Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L., Parkin D., et al. International classification of diseases for oncology (3e) 2000, World Health Organization, Geneva.
19. Burghardt E., Pickel H., Haas J., Lahousen M. Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am J Obstet Gynecol 1987, 156:988-996.
20. Okada M., Kigawa J., Minagawa Y., Kanamori Y., Shimada M., Takahashi M., et al. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer. Gynecol Oncol 1998, 70:61-64.
21. Yeh S.A., Wan Leung S., Wang C.J., Chen H.C. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol 1999, 72:10-15.
22. Ho C.M., Chien T.Y., Huang S.H., Wu C.J., Shih B.Y., Chang S.C. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004, 93:458-464.
23. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cervical Cancer. version 1.2012, 2012.
24. Park J.Y., Kim D.Y., Kim J.H., Kim Y.M., Kim Y.T., Nam J.H. Outcomes after radical hysterectomy according to tumor size divided by 2-cm interval in patients with early cervical cancer. Ann Oncol 2011, 22:59-67.
25. Bloss J.D., Berman M.L., Mukhererjee J., Manetta A., Emma D., Ramsanghani N.S., et al. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol Oncol 1992, 47:21-27.
26. Barter J.F., Soong S.J., Shingleton H.M., Hatch K.D., Orr J.W. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989, 32:292-296.
27. Fiorica J.V., Roberts W.S., Greenberg H., Hoffman M.S., LaPolla J.P., Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990, 36:343-347.
28. Morley G.W., Seski J.C. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976, 126:785-798.
29. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975, 123:535-542.
30. Eifel P.J., Morris M., Wharton J.T., Oswald M.J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994, 29:9-16.
31. Horn L.C., Fischer U., Raptis G., Bilek K., Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 2007, 107:310-315.